ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
126.161,79
0,50%
S&P 500
6.063,15
0,03%
US Dollar vs BRL
5,7654
-0,67%
Bitcoin
96.278,39
-0,35%
Brent Oil
74,09
-0,66%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Galera Therapeutics Inc (GRTX)

  7. Galera Therapeutics Inc (GRTX) Notícias

GRTX

Galera Therapeutics (GRTX)

Galera Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GRTX
DataHoraFonteTítuloCódigoCompanhia
31/12/202409:00GlobeNewswire Inc.Galera Therapeutics completes acquisition of Nova PharmaceuticalsNASDAQ:GRTXGalera Therapeutics Inc
23/08/202408:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GRTXGalera Therapeutics Inc
14/08/202408:00GlobeNewswire Inc.Galera Announces Board Approval of Complete Liquidation and DissolutionNASDAQ:GRTXGalera Therapeutics Inc
07/06/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
16/05/202411:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
16/05/202411:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
16/05/202411:25Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GRTXGalera Therapeutics Inc
13/05/202408:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
13/05/202408:00GlobeNewswire Inc.Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
03/05/202408:00GlobeNewswire Inc.Galera Adopts Limited Duration Stockholder Rights AgreementNASDAQ:GRTXGalera Therapeutics Inc
28/03/202408:00GlobeNewswire Inc.Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
26/02/202418:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
20/02/202420:57Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
14/11/202309:00GlobeNewswire Inc.Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
31/10/202309:09Dow Jones NewsGalera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 TrialNASDAQ:GRTXGalera Therapeutics Inc
31/10/202308:00GlobeNewswire Inc.Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateNASDAQ:GRTXGalera Therapeutics Inc
18/09/202308:00GlobeNewswire Inc.Galera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemNASDAQ:GRTXGalera Therapeutics Inc
05/09/202308:00GlobeNewswire Inc.Galera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRTXGalera Therapeutics Inc
14/08/202308:00GlobeNewswire Inc.Galera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
09/08/202321:10Dow Jones NewsStocks to Watch: Applovin, Disney, Galera TherapeuticsNASDAQ:GRTXGalera Therapeutics Inc
09/08/202318:23Dow Jones NewsGalera Therapeutics to Reduce Workforce by 70% to Extend Cash RunwayNASDAQ:GRTXGalera Therapeutics Inc
09/08/202317:31GlobeNewswire Inc.Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseNASDAQ:GRTXGalera Therapeutics Inc
28/06/202317:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRTXGalera Therapeutics Inc
16/06/202317:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRTXGalera Therapeutics Inc
05/06/202315:15GlobeNewswire Inc.Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual MeetingNASDAQ:GRTXGalera Therapeutics Inc
18/05/202309:44Dow Jones NewsGalera Therapeutics Gets Orphan Drug Designation for RucosopasemNASDAQ:GRTXGalera Therapeutics Inc
18/05/202309:00GlobeNewswire Inc.Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic CancerNASDAQ:GRTXGalera Therapeutics Inc
11/05/202317:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202308:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202308:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRTXGalera Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GRTX

Seu Histórico Recente

TG
LYY7
Amundi DAX III UCITS ETF...
TG
A28A
Affimed NV
USOTC
AGCZ
Andes Gold (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios